1,859
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems

ORCID Icon, , , , , , & show all
Pages 76-88 | Received 01 Nov 2019, Accepted 20 Dec 2019, Published online: 22 Jan 2020

References

  • Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–363.
  • Coccolini F, Gheza F, Lotti M, et al. Peritoneal carcinomatosis. WJG. 2013;19(41):6979–6994.
  • Helderman R, Loke DR, Kok HP, et al. Variation in clinical application of hyperthermic intraperitoneal chemotherapy: a review. Cancers. 2019;11(1):78.
  • Wu Q, Wu Q, Xu J, et al. Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis. Int J Hyperthermia. 2019;36(1):562–572.
  • Wisselink DD, Braakhuis LLF, Gallo G, et al. Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer. Crit Rev Oncol/Hematol. 2019;142:119–129.
  • Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro. Int J Hyperthermia. 2002;18(4):307–315.
  • Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–3743.
  • van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–240.
  • Tentes AA, Stamou K, Pallas N, et al. The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer. Int J Hyperthermia. 2016;32(8):895–899.
  • Sugarbaker PH. Strategies to improve local control of resected pancreas adenocarcinoma. Surg Oncol. 2017;26(1):63–70.
  • Zakris EL, Dewhirst MW, Riviere JE, et al. Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. JCO. 1987;5(10):1613–1620.
  • Jones E, Alvarez Secord A, Prosnitz LR, et al. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. Int J Hyperthermia. 2006;22(2):161–172.
  • Leopold KA, Oleson JR, Clarke-Pearson D, et al. Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. Int J Radiat Oncol Biol Phys. 1993;27(5):1245–1251.
  • Beck M, Ghadjar P, Weihrauch M, et al. Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis. Radiat Oncol. 2015;10(1):157.
  • Cho C, Wust P, Hildebrandt B, et al. Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators. Int J Hyperthermia. 2008;24(5):399–408.
  • Fotopoulou C, Cho CH, Kraetschell R, et al. Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: results of a pilot study. Int J Hyperthermia. 2010;26(2):118–126.
  • Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–497.
  • Crezee J, Van Haaren PMA, Westendorp H, et al. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: a preclinical study. Int J Hyperthermia. 2009;25(7):581–592.
  • Schneider CJ, van Dijk JD, De Leeuw AA, et al. Quality assurance in various radiative hyperthermia systems applying a phantom with LED matrix. Int J Hyperthermia. 1994;10(5):733–747.
  • Kok HP, Navarro F, Strigari L, et al. Locoregional hyperthermia of deep-seated tumours applied with capacitive and radiative systems: a simulation study. Int J Hyperthermia. 2018;34(6):714–730.
  • Paulsen KD, Geimer S, Tang J, et al. Optimization of pelvic heating rate distributions with electromagnetic phased arrays. Int J Hyperthermia. 1999;15(3):157–186.
  • Kroeze H, van de Kamer JB, De Leeuw AAC, et al. Regional hyperthermia applicator design using FDTD modelling. Phys Med Biol. 2001;46(7):1919–1935.
  • Wust P, Seebass M, Nadobny J, et al. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int J Hyperthermia. 1996;12(4):477–494.
  • De Greef M, Kok HP, Bel A, et al. 3-D versus 2-D steering in patient anatomies: a comparison using hyperthermia treatment planning. Int J Hyperthermia. 2011;27(1):74–85.
  • Canters RA, Paulides MM, Franckena M, et al. Benefit of replacing the Sigma-60 by the Sigma-Eye applicator. A Monte Carlo-based uncertainty analysis. Strahlenther Onkol. 2013;189(1):74–80.
  • Kok HP, Kotte A, Crezee J. Planning, optimisation and evaluation of hyperthermia treatments. Int J Hyperthermia. 2017;33(6):593–607.
  • De Bree J. A 3-D anatomy based treatment planning system for interstitial hyperthermia [PhD thesis]. Utrecht: Utrecht University; 1998.
  • Abe M, Hiraoka M, Takahashi M, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer. 1986;58(8):1589–1595.
  • Kroeze H, van de Kamer JB, de Leeuw AA, et al. Treatment planning for capacitive regional hyperthermia. Int J Hyperthermia. 2003;19(1):58–73.
  • Kato H, Hyodo K, Akasaka N, et al. Optimization of bolus for capacitive type heating. Jpn J Hyperthermic Oncol. 1997;13(1):10–17.
  • Kroeze H, Kokubo M, van de Kamer JB, et al. Comparison of a capacitive and a cavity slot radiative applicator for regional hyperthermia. Jpn J Hyperthermic Oncol. 2002;18(2):75–91.
  • van Dijk JD, Schneider C, van Os R, et al. Results of deep body hyperthermia with large waveguide radiators. Adv Exp Med Biol. 1990;267:315–319.
  • Zweije R, Kok HP, Bakker A, et al. Technical and clinical evaluation of the ALBA-4D 70MHz loco-regional hyperthermia system. Proceedings of the 48th European Microwave Conference; 2018. p. 328–331.
  • Turner PF, Tumeh A, Schaefermeyer T. BSD-2000 approach for deep local and regional hyperthermia: physics and technology. Strahlenther Onkol. 1989;165(10):738–741.
  • Van Rhoon GC, Van Der Heuvel DJ, Ameziane A, et al. Characterization of the SAR-distribution of the Sigma-60 applicator for regional hyperthermia using a Schottky diode sheet. Int J Hyperthermia. 2003;19(6):642–654.
  • Fatehi D, van Rhoon GC. SAR characteristics of the Sigma-60-Ellipse applicator. Int J Hyperthermia. 2008;24(4):347–356.
  • Van Haaren PMA, Kok HP, Wiersma J, et al. Faster EM-field calculations for locoregional hyperthermia treatment planning using the FDTD method. 21st Annual Meeting of the European Society for Hyperthermic Oncology, Abstract book, Munich, Germany; 2003. p. 137.
  • Van Haaren P, Kok P, Van Stam G, et al. Measurements and FDTD calculations in inhomogeneous phantom models. 9th International Congress on Hyperthermic Oncology, St.Louis, USA. Abstracts; 2004. p. 167.
  • de Bree J, van der Koijk JF, et al. A 3-D SAR model for current source interstitial hyperthermia. IEEE Trans Biomed Eng. 1996;43(10):1038–1045.
  • Taflove A, Hagness SC. Computational electrodynamics. 2nd ed. Boston, London: Artech House; 2000.
  • Berenger JP. A perfectly matched layer for the absorption of electromagnetic waves. Comput Phys. 1994;114(2):185–200.
  • Press WH, Flannery BP, Teukolsky SA, et al. Numerical recipes in C. Cambridge: Cambridge University Press; 1988.
  • ESHO Taskgroup Committee. Treatment planning and modelling in hyperthermia, a task group report of the European Society for Hyperthermic Oncology. Rome (Italy): Tor Vergata; 1992.
  • Gabriel S, Lau RW, Gabriel C. The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol. 1996;41(11):2251–2269.
  • Hasgall PA, Di Gennaro F, Baumgarter C, et al. IT’IS database for thermal and electromagnetic parameters of biological tissues. Version 3.0. Available from: www.itis.ethz.ch/database. 2015.
  • Hendifar AE, Petzel MQB, Zimmers TA, et al. on behalf of the Precision Promise Consortium. Pancreas cancer-associated weight loss. Oncologist. 2019;24(5):691–701.
  • Okura T, Fujii M, Shiode J, et al. Impact of body mass index on survival of pancreatic cancer patients in Japan. Acta Med Okayama. 2018;72(2):129–135.
  • Hornsleth SN, Mella O, Dahl O. A new segmentation algorithm for finite difference based treatment planning systems. In: Franconi C, Arcangeli G, Cavaliere R, editors. Hyperthermic oncology. Vol. 2. Rome (Italy): Tor Vergata; 1996. p. 521–523.
  • Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1(2):93–122.
  • Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984;44(10 Suppl):4721s–4730s.
  • Sreenivasa G, Gellermann J, Rau B, et al. Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity. Int J Radiat Oncol Biol Phys. 2003;55(2):407–419.
  • Ohguri T, Imada H, Yahara K, et al. Effect of 8-MHz radiofrequency-capacitive regional hyperthermia with strong superficial cooling for unresectable or recurrent colorectal cancer. Int J Hyperthermia. 2004;20(5):465–475.
  • Fatehi D, van der Zee J, Van Rhoon GC. Intra-patient comparison between two annular phased array applicators, Sigma-60 and Sigma-Eye: applied RF powers and intraluminally measured temperatures. Int J Hyperthermia. 2011;27(3):214–223.
  • Van Haaren PMA, Kok HP, Van den Berg CAT, et al. On verification of hyperthermia treatment planning for cervical carcinoma patients. Int J Hyperthermia. 2007;23(3):303–314.
  • Bergs JW, Haveman J, Ten Cate R, et al. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin. Oncol Rep. 2007;18(1):219–226.
  • De Greef M, Kok HP, Correia D, et al. Optimization in hyperthermia treatment planning: the impact of tissue perfusion uncertainty. Med Phys. 2010;37(9):4540–4550.
  • Kok HP, Crezee J. A comparison of the heating characteristics of capacitive and radiative superficial hyperthermia. Int J Hyperthermia. 2017;33(4):378–386.
  • Hiraoka M, Jo S, Akuta K, et al. Radiofrequency capacitive hyperthermia for deep-seated tumors. I. Studies on thermometry. Cancer. 1987;60(1):121–127.
  • Wust P, Beck R, Berger J, et al. Electric field distributions in a phased-array applicator with 12 channels: measurements and numerical simulations. Med Phys. 2000;27(11):2565–2579.
  • Wust P, Fahling H, Wlodarczyk W, et al. Antenna arrays in the SIGMA-eye applicator: interactions and transforming networks. Med Phys. 2001;28(8):1793–1805.
  • Weihrauch M, Wust P, Weiser M, et al. Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys. 2007;34(12):4717–4725.
  • Crezee J, Van Stam G, Sijbrands J, et al. Hyperthermia of deep seated pelvic tumors with a phased array of eight versus four 70 MHz waveguides. Proceedings of the 47th European Microwave Conference; 2017. p. 876–879.
  • Rettenmaier MA, Mendivil AA, Gray CM, et al. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia. 2015;31(4):396–402.
  • De Greef M, Correia D, Kok HP, et al. Hyperthermia treatment optimization: a search for alternative optimal settings as a backup during treatment. 25th Annual meeting of the European Society for Hyperthermic Oncology.Abstract book, Verona; June 2009.
  • Westermann AM, Grosen EA, Katschinski DM, et al. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. Eur J Cancer. 2001;37(9):1111–1117.
  • Hildebrandt B, Drager J, Kerner T, et al. Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study. Int J Hyperthermia. 2004;20(3):317–333.
  • Geijsen ED, De Reijke TM, Koning CCE, et al. Combining mitomycin C and regional 70 MHz hyperthermia in patients with nonmuscle invasive bladder cancer: a pilot study. J Urol. 2015;194(5):1202–1208.
  • Inman BA, Stauffer PR, Craciunescu OA, et al. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia. 2014;30(3):171–175.
  • Schooneveldt G, Kok HP, Bakker A, et al. Clinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic region. Int J Hyperthermia. 2018;35(1):383–397.
  • Kok HP, Van den Berg CAT, Bel A, et al. Fast thermal simulations and temperature optimization for hyperthermia treatment planning, including realistic 3D vessel networks. Med Phys. 2013;40(10):103303.
  • Kotte AN, van Leeuwen GM, Lagendijk JJ. Modelling the thermal impact of a discrete vessel tree. Phys Med Biol. 1999;44(1):57–74.
  • Bruggmoser G, Bauchowitz S, Canters R, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol. 2011;187(10):605–610.
  • Winter L, Oberacker E, Paul K, et al. Magnetic resonance thermometry: methodology, pitfalls and practical solutions. Int J Hyperthermia. 2016;32(1):63–75.
  • Kok HP, de Kroon-Oldenhof R, van Straten LK, et al. RF heating of pancreatic tumours guided by hyperthermia treatment planning and limited thermometry. Proceedings of the 48th European Microwave Conference; 2018. p. 332–335.
  • Kok HP, Korshuize-van Straten L, Bakker A, et al. On-line adaptive hyperthermia treatment planning during locoregional heating to suppress treatment limiting hot spots. Int J Radiat Oncol Biol Phys. 2017;99(4):1039–1047.
  • Kok HP, Korshuize-van Straten L, Bakker A, et al. Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia. Int J Hyperthermia. 2018;34(7):1082–1091.